Siemens Healthineers falls as guidance cut overshadows strong orders
BUZZ-Siemens Healthineers falls as guidance cut overshadows strong orders ** Shares in Siemens Healthineers SHLG.DE fall 4.6% in early Frankfurt trade as the cut to its 2026 revenue growth forecast overshadows strong orders and a higher earnings outlook
** The company cut its FY revenue growth forecast to 3.5%-4.0% from 5%-6%, while raising EPS guidance to €2.35-2.45 due to U.S. tariff refunds
** A local trader points to the lower sales growth outlook as reflecting an "ongoing dull Diagnostics business", despite a "very pleasing" book-to-bill ratio
** JPMorgan says the quarter's "key highlight" was a book-to-bill ratio of 1.27, but notes revenue missed expectations amid softer Imaging sales and continued Diagnostics weakness in China
** The EPS guidance increase mainly reflects U.S. tariff refunds, while management's FY27 commentary suggests "double-digit EPS growth in FY27 is unlikely", the broker adds
** The stock is down about 17.2% YTD as of Thursday's close
($1 = 0.8685 euros)
(Reporting by Kira Britten and Simon Ferdinand Eibach)
Recent news on Siemens Healthineers AG
See all newsSiemens Healthineers forecasts slower 2027 growth as China weakness persists (updated)
Siemens Healthineers seen sliding after 'not good enough' outlook
Siemens Healthineers begins carve-out of diagnostics unit amid China weakness (updated)
Brief: Siemens Healthineers - For FY 2027, Expect Comparable Revenue Growth Between 4.0% And 5.0% Over FY 2026
Siemens Healthineers starts Diagnostics carve-out, names unit Olyrian